Introduction to Introduction Molecular Testing In Ovarian Cancer
If you are looking for information about Introduction Molecular Testing In Ovarian Cancer, you have come to the right place. Bradley J. Monk, MD, and Angeles Alvarez Secord, MD, explain histological subtypes and gene mutations found in
Introduction Molecular Testing In Ovarian Cancer Comprehensive Overview
Whitney S. Graybill, MD, MS, discusses the clinical use of BRCA1/2 Bradley J. Monk, MD, FACS, FACOG; Kathleen Moore, MD; Leslie M. Randall, MD, MAS; Oliver Dorigo, MD, PhD; and Thomas ... Bradley J. Monk, MD, FACS, FACOG; David O'Malley, MD; Ursula Matulonis, MD; Shannon N. Westin, MD, MPH; and Matthew ...
Oliver Dorigo, MD, PhD, and Matthew Powell, MD, share insight on how to optimize
Summary & Highlights for Introduction Molecular Testing In Ovarian Cancer
- Sarah E. Taylor, MD, discusses
- Watch Dr ElNaggar discuss the clinical utility of homologous recombination deficiency (HRD) and how
- Shannon Westin, MD, discusses the role of
- Matthew A. Powell, MD, reviews the current recommendations for
- Presenter: Rob Dood, MD, Department of Obstetrics & Gynecology, Division of Gynecology
We hope this detailed breakdown of Introduction Molecular Testing In Ovarian Cancer was helpful.
